Biocryst Pharmaceuticals (BCRX) P/E (2012 - 2026)
Biocryst Pharmaceuticals (BCRX) P/E from Jan 3, 2012 to Jun 2, 2026. The TTM Biocryst Pharmaceuticals (BCRX) P/E is -5.21. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Biocryst Pharmaceuticals (BCRX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -5.21 | -182.72% |
| 2025 | 6.29 | -135.90% |
| 2024 | -17.53 | +266.13% |
| 2023 | -4.79 | -56.58% |
| 2022 | -11.03 | -18.23% |
| 2021 | -13.49 | +92.93% |
| 2020 | -6.99 | +98.53% |
| 2019 | -3.52 | -57.82% |
| 2018 | -8.35 | +2.27% |
| 2017 | -8.16 | +20.45% |
| 2016 | -6.78 | -61.34% |
| 2015 | -17.53 | -5.34% |
| 2014 | -18.52 | +31.45% |
| 2013 | -14.09 | +669.56% |
| 2012 | -1.83 | N/A |
Comparison Biocryst Pharmaceuticals (BCRX) P/E with competitors
Biocryst Pharmaceuticals (BCRX) P/E is -5.21.